Monday, 26 October 2026European Markets

OKEANIS ECO TANKER And EIFFAGE Have A High Dividend Yield And Return On Equity In The Industrials Sector.

Loading stream...

(vianews) - okeanis eco tanker (oet.ol) is among this list of stock assets with the highest dividend rate and return on equity on the industrials sector.

financial asset price forward dividend yield return on equity
okeanis eco tanker (oet.ol) kr242.00 7.23% 21.67%
eiffage (fgr.pa) €100.30 3.02% 19.06%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. okeanis eco tanker (oet.ol)

7.23% forward dividend yield and 21.67% return on equity

okeanis eco tankers corp., a tanker company, engages in the ownership, chartering and operation of oil tanker vessels worldwide. the company also provides various shipping services, such as technical support, maintenance, and insurance consulting services. it operates a fleet of six modern scrubber-fitted suezmax tankers, seven modern scrubber-fitted vlcc tankers, and a vlcc tanker. the company was incorporated in 2018 and is based in piraeus, greece.

earnings per share

as for profitability, okeanis eco tanker has a trailing twelve months eps of kr-2.17.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.67%.

sales growth

okeanis eco tanker's sales growth for the current quarter is 293.1%.

volatility

okeanis eco tanker's last week, last month's, and last quarter's current intraday variation average was a negative 1.84%, a positive 1.58%, and a positive 2.34%.

okeanis eco tanker's highest amplitude of average volatility was 1.98% (last week), 3.22% (last month), and 2.34% (last quarter).

more news about okeanis eco tanker.

2. eiffage (fgr.pa)

3.02% forward dividend yield and 19.06% return on equity

eiffage sa engages in the construction, property development, urban development, civil engineering, metallic construction, roads, energy systems, and concessions businesses in france and internationally. the company construction segment offers urban development, building design and construction, property development, and maintenance and services works. its infrastructure segment is involved in undertaking civil engineering, road and rail design and construction, drainage, earthworks, and metallic construction. the company's energy systems segment designs, constructs, integrates, operates, and maintains energy and telecommunication systems and equipment. its concessions segment constructs and manages concession contracts and public-private partnerships. the company was incorporated in 1920 and is headquartered in vélizy-villacoublay, france.

earnings per share

as for profitability, eiffage has a trailing twelve months eps of €3.8.

pe ratio

eiffage has a trailing twelve months price to earnings ratio of 26.39. meaning, the purchaser of the share is investing €26.39 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.06%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, eiffage's stock is considered to be overbought (>=80).

dividend yield

as claimed by morningstar, inc., the next dividend payment is on may 16, 2022, the estimated forward annual dividend rate is 3.1 and the estimated forward annual dividend yield is 3.02%.

more news about eiffage.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com